SIK2 and breast carcinoma: The results confirm our in vitro findings (Figure 2A) with respect to the inverse correlation between SIK2 levels and mitotic ability of cells in vivo and support our hypothesis that SIK2 activity contributes to the inhibition of breast cancer cell proliferation.